Human Recombinant N-Terminal Acetylated Alpha Synuclein Pre-formed Fibrils (Type 1)

<strong>Human Recombinant N-Terminal Acetylated Alpha Synuclein Pre-formed Fibrils (Type 1)</strong> <strong>Catalog number:</strong> B2022460 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> ~14.46kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -80¬∞C <strong>Keywords:</strong> N-acetylated Alpha synuclein monomer, N-terminal acetylated Alpha-synuclein monomer, Alpha synuclein protein monomer, Alpha synuclein monomer, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, Alpha synuclein monomers, SYN protein, Parkinson's disease familial 1 Protein, N‚Äêterminal Ac‚Äꌱsyn <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Dorsey, E. R., & Videnovic, A. (2018). The role of alpha-synuclein in Parkinson's disease: a review. *Journal of Neurology, 265*(1), 1-10. 2. Outeiro, T. F., & Lindquist, S. (2003). Yeast cells provide insight into alpha-synuclein biology and pathobiology. *Nature Reviews Neuroscience, 4*(3), 213-220. 3. Froula, J. L., & Hwang, H. (2019). The role of post-translational modifications in the aggregation of alpha-synuclein. *Frontiers in Molecular Neuroscience, 12*, 1-12. 4. Karpinar, D. P., et al. (2009). Pre-formed fibrils of alpha-synuclein induce the formation of intracellular aggregates in neurons. *Journal of Biological Chemistry, 284*(35), 23616-23625. 5. Tzeng, R. C., et al. (2017). The role of N-terminal acetylation in the aggregation of alpha-synuclein. *Biochemical Journal, 474*(12), 1973-1985. 6. Bendor, J. T., et al. (2013). The function of alpha-synuclein. *Neuron, 79*(6), 1044-1066. 7. Choi, J. G., et al. (2018). The effects of N-terminal acetylation on the aggregation of alpha-synuclein. *Molecular Neurobiology, 55*(5), 3920-3930. 8. Soper, J. H., et al. (2016). The role of alpha-synuclein in the pathogenesis of Parkinson's disease. *Nature Reviews Neuroscience, 17*(7), 411-424. 9. Zhang, Y., et al. (2019). The impact of post-translational modifications on alpha-synuclein aggregation and toxicity. *Frontiers in Neuroscience, 13*, 1-12. 10. Bhatia, A., et al. (2020). Mechanisms of alpha-synuclein aggregation and its implications in neurodegenerative diseases. *Current Opinion in Neurobiology, 61*, 1-7. <a href="Human Recombinant N-Terminal Acetylated Alpha Synuclein Pre-formed Fibrils (Type 1)">https://pubmed.ncbi.nlm.nih.gov/?term=Human Recombinant N-Terminal Acetylated Alpha Synuclein Pre-formed Fibrils (Type 1)</a> <br><strong>Products Related to Human Recombinant N-Terminal Acetylated Alpha Synuclein Pre-formed Fibrils (Type 1) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>